Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
News
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage…
IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
IO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior Vice President, Commercial and Program Lead
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
Dyadic to Participate at Upcoming Events in June
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Dyadic to Participate at Upcoming Events in June
JUPITER, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”)…
Veru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board
MIAMI, FL, June 01, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
Veru Announces Appointment of Dr. Erik Swenson and Dr. Robert Schooley to its Infectious Disease Scientific Advisory Board
MIAMI, FL, June 01, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
Coherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023
List price of $995 per carton for two 40 mg/0.8 mL autoinjectors REDWOOD CITY, Calif.,…
Coherus Announces Industry-Wide Lowest List Price for Adalimumab Biosimilar YUSIMRY™ (adalimumab-aqvh) Launching in July 2023
List price of $995 per carton for two 40 mg/0.8 mL autoinjectors REDWOOD CITY, Calif.,…
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
MINNEAPOLIS, June 01, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…
LAVA Therapeutics to Participate in the Jefferies Healthcare Conference
UTRECHT, The Netherlands and PHILADELPHIA, June 01, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
LAVA Therapeutics to Participate in the Jefferies Healthcare Conference
UTRECHT, The Netherlands and PHILADELPHIA, June 01, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts…
Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023
Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million Forecasts…
Rani Therapeutics to Present at the Jefferies Healthcare Conference
SAN JOSE, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
Rani Therapeutics to Present at the Jefferies Healthcare Conference
SAN JOSE, Calif., June 01, 2023 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
Oculis to Participate in Jefferies Healthcare Conference
ZUG, Switzerland and BOSTON, June 01, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…
Oculis to Participate in Jefferies Healthcare Conference
ZUG, Switzerland and BOSTON, June 01, 2023 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS)…